Загрузка...
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
BACKGROUND: Chemotherapy resistance presents a difficult challenge in treating epithelial ovarian cancer patients, particularly when tumors exhibit resistance to multiple chemotherapeutic agents. A few studies have shown that elevated serum levels of the ovarian cancer biomarker HE4 correlate with t...
Сохранить в:
| Опубликовано в: : | J Ovarian Res |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869286/ https://ncbi.nlm.nih.gov/pubmed/27184254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0240-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|